Mesenchymal Stem Cells in Liver Diseases: Present Status and Future Perspectives

Bibliographic Information
Authors: Atta S.; Megahed F.; Atta A.H.
Journal: Experimental and Clinical Transplantation
Publisher: Baskent University
Publication Date: August 2024
Volume / Issue: Volume 22 / Issue 8
Pages: 586–599
ISSN: 13040855
Scopus: View on Scopus
PubMed: 39254070
Document Type: Review
Authors and Affiliations
Atta S., Department of Immunology, Theodor Bilharz Research Institute, Cairo, Egypt; Megahed F., Department of Nucleic Acid Research Department, Genetic Engineering and Biotechnological Research Institute (GEBRI), City for Scientific Researches and Technological Applications (SRTA-City), Alexandria, 21934, Egypt; Atta A.H., Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Cairo, Egypt
Abstract
Liver disease is a major worldwide health and economic problem. Allograft liver transplant is the only effective therapy for end-stage liver disease. The shortage of donors, the high costs, postoperative complications, and lifelong immunosuppression are rate-limiting factors for this established line of treatment. Hence, searching for therapeutic alter-natives is mandatory. Stem cells are attractive candi-dates for cell-based therapy for their potential to support liver regeneration with few complications. They can differentiate into specialized cells, including hepatocytes to restore liver structure and function. Stem cells originating from different sources have been investigated for the treatment of liver diseases. In this review, we highlight the role of stem cells as an appropriate source for liver cell replacement in different liver diseases. © Başkent University 2024.
Keywords
Cirrhosis; End-stage liver disease; Liver regeneration; Animals; Cell Differentiation; Hepatocytes; Humans; Liver; Liver Diseases; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Phenotype; Recovery of Function; Regenerative Medicine; Treatment Outcome; allograft; cell therapy; end stage liver disease; fibrosis; human; immune deficiency; immunosuppressive treatment; line of treatment; liver cell; liver disease; liver structure; liver transplantation; mesenchymal stem cell; nonhuman; pharmacokinetics; postoperative complication; review; therapy; animal; convalescence; pathology; surgery; transplantation
Citation Information
Scopus Citations: 1
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
